[go: up one dir, main page]

AU2001233715A1 - Dermo- and gastro-specific sphingolipid activator - Google Patents

Dermo- and gastro-specific sphingolipid activator

Info

Publication number
AU2001233715A1
AU2001233715A1 AU2001233715A AU3371501A AU2001233715A1 AU 2001233715 A1 AU2001233715 A1 AU 2001233715A1 AU 2001233715 A AU2001233715 A AU 2001233715A AU 3371501 A AU3371501 A AU 3371501A AU 2001233715 A1 AU2001233715 A1 AU 2001233715A1
Authority
AU
Australia
Prior art keywords
dermo
gastro
sphingolipid activator
specific sphingolipid
specific
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233715A
Inventor
Marcus Conradt
Kay Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEMOREC MEDICAL MOLECULAR RESEARCH COLOGNE STOFFEL GmbH
Original Assignee
MEMOREC MEDICAL MOLECULAR RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEMOREC MEDICAL MOLECULAR RES filed Critical MEMOREC MEDICAL MOLECULAR RES
Publication of AU2001233715A1 publication Critical patent/AU2001233715A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001233715A 2000-01-26 2001-01-26 Dermo- and gastro-specific sphingolipid activator Abandoned AU2001233715A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10003154.4 2000-01-26
DE10003154 2000-01-26
PCT/EP2001/000877 WO2001055198A2 (en) 2000-01-26 2001-01-26 Dermo- and gastro-specific sphingolipid activator

Publications (1)

Publication Number Publication Date
AU2001233715A1 true AU2001233715A1 (en) 2001-08-07

Family

ID=7628688

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233715A Abandoned AU2001233715A1 (en) 2000-01-26 2001-01-26 Dermo- and gastro-specific sphingolipid activator

Country Status (2)

Country Link
AU (1) AU2001233715A1 (en)
WO (1) WO2001055198A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2389724A1 (en) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 28 human secreted proteins
WO2004084930A1 (en) * 2003-03-26 2004-10-07 Develogen Aktiengesellschaft Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700909A (en) * 1993-07-30 1997-12-23 The Regents Of The University Of California Prosaposin and cytokine-derived peptides
JP2001515866A (en) * 1997-09-09 2001-09-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Inhibition of apoptosis using prosaposin receptor agonist
WO2000002902A1 (en) * 1998-07-13 2000-01-20 Gill Parkash S Novel inhibitors of angiogenesis and tumor growth
JP2002524025A (en) * 1998-07-23 2002-08-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー Human SBPSAPL gene with homology to the prosaposin family of neurotrophic factors
DE60041694D1 (en) * 1999-03-17 2009-04-16 Womens & Childrens Hospital NOW USE OF SAPOSINS AND OTHER MARKERS
FR2797402B1 (en) * 1999-07-15 2004-03-12 Biomerieux Stelhys USE OF A POLYPEPTIDE FOR DETECTING, PREVENTING OR TREATING A CONDITION ASSOCIATED WITH A DEGENERATIVE, NEUROLOGICAL OR AUTOIMMUNE DISEASE

Also Published As

Publication number Publication date
WO2001055198A9 (en) 2003-08-14
WO2001055198A2 (en) 2001-08-02
WO2001055198A3 (en) 2002-03-14

Similar Documents

Publication Publication Date Title
AU2002219555A1 (en) VLA-4 Inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2002211431A1 (en) Bleed-resistant dry-transfer wallcoverings
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002357860A1 (en) Enzymes
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001266345A1 (en) Five-membered-ring compound
EP1151667A3 (en) Plant-activating agent
AU5248800A (en) Fading inhibitors
AU2002363129A1 (en) Collaboration-enabled enterprise
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001241098A1 (en) Composition
AU2002347778A1 (en) Enzymes
AU2001275201A1 (en) Acne-treating composition
AU2001230689A1 (en) Novel compounds
AUPQ575300A0 (en) New compound
AU2001287852A1 (en) Composition
AU2002337150A1 (en) Microchamber
AU2001233715A1 (en) Dermo- and gastro-specific sphingolipid activator
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001223878A1 (en) Sealant
AU2001262163A1 (en) Composition
AU2001274683A1 (en) Contrast agents
AU2001274750A1 (en) Novel beta-hydroxyamides
AU2002257273A1 (en) Enzymes